Kansas City, MO, United States

Cerner Corporation

www.cerner.com
Kansas City, MO, United States

Cerner Corporation is a supplier of health care information technology solutions, services, devices and hardware. Cerner solutions optimize processes for health care organizations. These solutions are currently licensed by approximately 9,300 facilities around the world, including more than 2,650 hospitals, 3,750 physician practices, 40,000 physicians, 500 ambulatory facilities, 800 home health facilities, 40 employer sites, and 1,600 retail pharmacies. As of December 2013, the company had more than 14,200 employees globally. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

News Article | May 25, 2017
Site: globenewswire.com

KANSAS CITY, Mo., May 25, 2017 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced that its board of directors approved a stock repurchase program on May 23, 2017, authorizing the repurchase of up to $500 million of its common stock.  “We believe Cerner is very well-positioned for long-term growth, and this program reflects our confidence in delivering this growth,” said Marc Naughton, executive vice president and CFO of Cerner. “Given our strong balance sheet and expected strong cash flow, we are well positioned to continue investing in growth while also returning value to shareholders through share repurchases.  The Board of Directors and our leadership team believe Cerner’s shares are an attractive investment, and share repurchases are an important part of our capital allocation strategy.” The company plans to repurchase shares from time to time in the open market, by block purchase, or possibly through other transactions managed by broker-dealers. No time limit was set for completion of the program. Based on the May 24, 2017 closing price, approximately 7.8 million shares, or 2.3 percent of the company’s outstanding shares, could be repurchased. The repurchase will be funded from working capital. There is approximately $100 million remaining under the previous stock repurchase program approved by Cerner's board of directors in November 2016. Cerner's health information technologies connect people, information and systems at more than 25,000 facilities worldwide. Recognized for innovation, Cerner® solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, or connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors. Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “believe”, “expect”, “position” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of significant costs and reputational harm related to product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; the possibility of increased expenses, exposure to legal claims and regulatory actions and reputational harm associated with a cyberattack or other breach in our IT security; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; potential claims or other risks associated with relying on open source software in our proprietary software, solutions or services; material adverse resolution of legal proceedings; risks associated with our global operations; risks associated with fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the U.S. and non-U.S. countries; the uncertainty surrounding the impact of the United Kingdom’s vote to leave the European Union (commonly referred to as Brexit) on our global business; risks associated with our recruitment and retention of key personnel; risks related to our dependence on strategic partners and third party suppliers; difficulties and operational and financial risks associated with successfully completing the integration of the Cerner Health Services (formerly Siemens Health Services) business into our business or the failure to realize the synergies and other benefits expected from the acquisition; risks inherent with business acquisitions and combinations and the integration thereof; the potential for losses resulting from asset impairment charges; risks associated with volatility and disruption resulting from global economic or market conditions; managing growth in the new markets in which we offer solutions, health care devices or services; risks inherent in contracting with government clients; risks associated with our outstanding and future indebtedness, such as compliance with restrictive covenants, which may limit our flexibility to operate our business; changing political, economic, regulatory and judicial influences, which could impact the purchasing practices and operations of our clients and increase costs to deliver compliant solutions and services; government regulation; significant competition and our ability to quickly respond to market changes and changing technologies and to bring competitive new solutions, devices, features and services to market in a timely fashion; long sales cycles for our solutions and services; variations in our quarterly operating results; potential variations in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors’ authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; and changes in accounting standards issued by the Financial Accounting Standards Board or other standard-setting bodies may adversely affect our financial statements. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Except as required by law, Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.


News Article | May 24, 2017
Site: www.businesswire.com

SAN FRANCISCO--(BUSINESS WIRE)--Scout RFP, a leader in cloud-based strategic e-sourcing solutions, announced today that it has been named one of Gartner’s 2017 “Cool Vendors” in Procurement and Sourcing Technology.1 The report identifies interesting, new and innovative vendors, products and services. It also explores key findings and recommendations for procurement and IT leaders to keep their businesses compliant and operating at peak performance. A complimentary copy of Gartner’s report can be found here. The Gartner report recognizes “vendors delighting customers with innovation and positive business impacts.” Gartner goes on to share, the technology solutions of the evaluated “vendors bring a refreshingly new, disruptive approach to solving age-old problems in the procurement and sourcing domain.”1 Scout’s cloud-based eSourcing platform enables companies to streamline supplier selection, centralize data, and make faster, more informed purchasing decisions. Its strategic sourcing, pipeline, intake, and eAuction tools help procurement professionals source fast and make a bigger business impact. “We are thrilled to receive the Cool Vendor recognition from Gartner and feel it validates our vision,” said Scout RFP CEO Alex Yakubovich. “Over the last 17 months, we’ve experienced rapid growth and are excited that our customers’ feedback matches Gartner’s assessment. Scout has been deployed globally by some of the world’s leading enterprises and our sourcing platform is enabling the enterprise to execute truly strategic sourcing.” Scout’s inclusion on Gartner’s Cool Vendors list follows the release of its HBR Analytic Services procurement industry research, which explores the critical roles that sourcing, procurement, and supply chain management play in enterprise success. The new research paper includes insights from leaders at Accenture, Adobe, Bradken Limited, Deloitte, Intuit, Levi Strauss & Co., Owens Corning, Uber, and VSP Global. Click here to access Gartner’s 2017 Cool Vendors in Procurement and Sourcing Technology report. For more information on Scout RFP, visit www.scoutrfp.com or watch the product overview video. 1 Gartner, Cool Vendors in Procurement and Sourcing Technology, 2017, Desere Edwards, Deborah R Wilson, Magnus Bergfors, May 15, 2017 Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. Scout, also known as Scout RFP, provides a new breed of cloud-based strategic sourcing solutions that help organizations achieve better outcomes and make a bigger impact. Leading brands like Intuit, CEMEX, Splunk, Jo-Ann Stores, ServiceNow, Cerner Corporation, EasyJet, and Zebra Technologies trust Scout’s automated sourcing and auction platform to deliver greater value through collaborative business engagement. 27,000 active users across 89 countries have chosen Scout’s simple, effective interface to streamline supplier selection, centralize data, and make more informed purchasing decisions, faster. Scout is headquartered in San Francisco, and funded by New Enterprise Associates (NEA) and GV (formerly Google Ventures). To learn more, please visit scoutrfp.com and follow us on Twitter @scoutrfp or LinkedIn.


News Article | May 25, 2017
Site: globenewswire.com

KANSAS CITY, Mo., May 25, 2017 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced that its board of directors approved a stock repurchase program on May 23, 2017, authorizing the repurchase of up to $500 million of its common stock.  “We believe Cerner is very well-positioned for long-term growth, and this program reflects our confidence in delivering this growth,” said Marc Naughton, executive vice president and CFO of Cerner. “Given our strong balance sheet and expected strong cash flow, we are well positioned to continue investing in growth while also returning value to shareholders through share repurchases.  The Board of Directors and our leadership team believe Cerner’s shares are an attractive investment, and share repurchases are an important part of our capital allocation strategy.” The company plans to repurchase shares from time to time in the open market, by block purchase, or possibly through other transactions managed by broker-dealers. No time limit was set for completion of the program. Based on the May 24, 2017 closing price, approximately 7.8 million shares, or 2.3 percent of the company’s outstanding shares, could be repurchased. The repurchase will be funded from working capital. There is approximately $100 million remaining under the previous stock repurchase program approved by Cerner's board of directors in November 2016. Cerner's health information technologies connect people, information and systems at more than 25,000 facilities worldwide. Recognized for innovation, Cerner® solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, or connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors. Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “believe”, “expect”, “position” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of significant costs and reputational harm related to product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; the possibility of increased expenses, exposure to legal claims and regulatory actions and reputational harm associated with a cyberattack or other breach in our IT security; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; potential claims or other risks associated with relying on open source software in our proprietary software, solutions or services; material adverse resolution of legal proceedings; risks associated with our global operations; risks associated with fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the U.S. and non-U.S. countries; the uncertainty surrounding the impact of the United Kingdom’s vote to leave the European Union (commonly referred to as Brexit) on our global business; risks associated with our recruitment and retention of key personnel; risks related to our dependence on strategic partners and third party suppliers; difficulties and operational and financial risks associated with successfully completing the integration of the Cerner Health Services (formerly Siemens Health Services) business into our business or the failure to realize the synergies and other benefits expected from the acquisition; risks inherent with business acquisitions and combinations and the integration thereof; the potential for losses resulting from asset impairment charges; risks associated with volatility and disruption resulting from global economic or market conditions; managing growth in the new markets in which we offer solutions, health care devices or services; risks inherent in contracting with government clients; risks associated with our outstanding and future indebtedness, such as compliance with restrictive covenants, which may limit our flexibility to operate our business; changing political, economic, regulatory and judicial influences, which could impact the purchasing practices and operations of our clients and increase costs to deliver compliant solutions and services; government regulation; significant competition and our ability to quickly respond to market changes and changing technologies and to bring competitive new solutions, devices, features and services to market in a timely fashion; long sales cycles for our solutions and services; variations in our quarterly operating results; potential variations in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors’ authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; and changes in accounting standards issued by the Financial Accounting Standards Board or other standard-setting bodies may adversely affect our financial statements. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Except as required by law, Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.


News Article | May 25, 2017
Site: globenewswire.com

KANSAS CITY, Mo., May 25, 2017 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced that its board of directors approved a stock repurchase program on May 23, 2017, authorizing the repurchase of up to $500 million of its common stock.  “We believe Cerner is very well-positioned for long-term growth, and this program reflects our confidence in delivering this growth,” said Marc Naughton, executive vice president and CFO of Cerner. “Given our strong balance sheet and expected strong cash flow, we are well positioned to continue investing in growth while also returning value to shareholders through share repurchases.  The Board of Directors and our leadership team believe Cerner’s shares are an attractive investment, and share repurchases are an important part of our capital allocation strategy.” The company plans to repurchase shares from time to time in the open market, by block purchase, or possibly through other transactions managed by broker-dealers. No time limit was set for completion of the program. Based on the May 24, 2017 closing price, approximately 7.8 million shares, or 2.3 percent of the company’s outstanding shares, could be repurchased. The repurchase will be funded from working capital. There is approximately $100 million remaining under the previous stock repurchase program approved by Cerner's board of directors in November 2016. Cerner's health information technologies connect people, information and systems at more than 25,000 facilities worldwide. Recognized for innovation, Cerner® solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, or connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors. Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “believe”, “expect”, “position” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of significant costs and reputational harm related to product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; the possibility of increased expenses, exposure to legal claims and regulatory actions and reputational harm associated with a cyberattack or other breach in our IT security; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; potential claims or other risks associated with relying on open source software in our proprietary software, solutions or services; material adverse resolution of legal proceedings; risks associated with our global operations; risks associated with fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the U.S. and non-U.S. countries; the uncertainty surrounding the impact of the United Kingdom’s vote to leave the European Union (commonly referred to as Brexit) on our global business; risks associated with our recruitment and retention of key personnel; risks related to our dependence on strategic partners and third party suppliers; difficulties and operational and financial risks associated with successfully completing the integration of the Cerner Health Services (formerly Siemens Health Services) business into our business or the failure to realize the synergies and other benefits expected from the acquisition; risks inherent with business acquisitions and combinations and the integration thereof; the potential for losses resulting from asset impairment charges; risks associated with volatility and disruption resulting from global economic or market conditions; managing growth in the new markets in which we offer solutions, health care devices or services; risks inherent in contracting with government clients; risks associated with our outstanding and future indebtedness, such as compliance with restrictive covenants, which may limit our flexibility to operate our business; changing political, economic, regulatory and judicial influences, which could impact the purchasing practices and operations of our clients and increase costs to deliver compliant solutions and services; government regulation; significant competition and our ability to quickly respond to market changes and changing technologies and to bring competitive new solutions, devices, features and services to market in a timely fashion; long sales cycles for our solutions and services; variations in our quarterly operating results; potential variations in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors’ authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; and changes in accounting standards issued by the Financial Accounting Standards Board or other standard-setting bodies may adversely affect our financial statements. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Except as required by law, Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.


News Article | May 25, 2017
Site: globenewswire.com

KANSAS CITY, Mo., May 25, 2017 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced that its board of directors approved a stock repurchase program on May 23, 2017, authorizing the repurchase of up to $500 million of its common stock.  “We believe Cerner is very well-positioned for long-term growth, and this program reflects our confidence in delivering this growth,” said Marc Naughton, executive vice president and CFO of Cerner. “Given our strong balance sheet and expected strong cash flow, we are well positioned to continue investing in growth while also returning value to shareholders through share repurchases.  The Board of Directors and our leadership team believe Cerner’s shares are an attractive investment, and share repurchases are an important part of our capital allocation strategy.” The company plans to repurchase shares from time to time in the open market, by block purchase, or possibly through other transactions managed by broker-dealers. No time limit was set for completion of the program. Based on the May 24, 2017 closing price, approximately 7.8 million shares, or 2.3 percent of the company’s outstanding shares, could be repurchased. The repurchase will be funded from working capital. There is approximately $100 million remaining under the previous stock repurchase program approved by Cerner's board of directors in November 2016. Cerner's health information technologies connect people, information and systems at more than 25,000 facilities worldwide. Recognized for innovation, Cerner® solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, or connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors. Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “believe”, “expect”, “position” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of significant costs and reputational harm related to product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; the possibility of increased expenses, exposure to legal claims and regulatory actions and reputational harm associated with a cyberattack or other breach in our IT security; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; potential claims or other risks associated with relying on open source software in our proprietary software, solutions or services; material adverse resolution of legal proceedings; risks associated with our global operations; risks associated with fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the U.S. and non-U.S. countries; the uncertainty surrounding the impact of the United Kingdom’s vote to leave the European Union (commonly referred to as Brexit) on our global business; risks associated with our recruitment and retention of key personnel; risks related to our dependence on strategic partners and third party suppliers; difficulties and operational and financial risks associated with successfully completing the integration of the Cerner Health Services (formerly Siemens Health Services) business into our business or the failure to realize the synergies and other benefits expected from the acquisition; risks inherent with business acquisitions and combinations and the integration thereof; the potential for losses resulting from asset impairment charges; risks associated with volatility and disruption resulting from global economic or market conditions; managing growth in the new markets in which we offer solutions, health care devices or services; risks inherent in contracting with government clients; risks associated with our outstanding and future indebtedness, such as compliance with restrictive covenants, which may limit our flexibility to operate our business; changing political, economic, regulatory and judicial influences, which could impact the purchasing practices and operations of our clients and increase costs to deliver compliant solutions and services; government regulation; significant competition and our ability to quickly respond to market changes and changing technologies and to bring competitive new solutions, devices, features and services to market in a timely fashion; long sales cycles for our solutions and services; variations in our quarterly operating results; potential variations in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors’ authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; and changes in accounting standards issued by the Financial Accounting Standards Board or other standard-setting bodies may adversely affect our financial statements. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Except as required by law, Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.


News Article | May 8, 2017
Site: www.prnewswire.com

The global pharmacy automation market is projected to reach USD 5.38 Billion by 2022, at a CAGR of 8.2% from 2017 to 2022. The market growth can be attributed to a number of factors such as the growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs. Automated medication dispensing systems accounted for the largest share of the pharmacy automation market in 2016. Decentralized automated dispensing system is expected to be the fastest growing product segment in the automated medication dispensing systems market during the forecast period. This is mainly attributed to the rising demand for accurate and timely dispensing of a treatment regimen and the need for avoiding dispensing errors associated with the type and dosage of commonly prescribed medication. Retail pharmacies is expected to be the fastest growing end user segment in the pharmacy automation market during the forecast period. Rising number of retail pharmacies and increasing workload on pharmacists are the major factors driving the rising adoption of pharmacy automation systems in retail pharmacies. In 2016, North America accounted for the largest share of the global pharmacy automation market, largely attributed to the increasing number of drug prescriptions at pharmacies resulting from growth in the aging population. Furthermore, growth in insurance coverage in the U.S. has increased the burden on the country's healthcare system, which has highlighted the need for improving efficiency and management of work in North America. With the rapid rise in the number of patients, demand for quality care, and effective upgradation of the healthcare IT infrastructure is expected to have a positive impact on the demand for pharmacy automation systems market in APAC and Latin America. The major players in the pharmacy automation market are Becton, Dickinson, and Company (U.S.), Omnicell, Inc. (U.S.), Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst systems LLC. (U.S.). For more information about this report visit http://www.researchandmarkets.com/research/dzthk2/pharmacy Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-pharmacy-automation-market-2017---forecast-to-2022---research-and-markets-300453236.html


— The global ambulatory EHR market is expected to reach USD 5.20 billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). The ambulatory EHR market is undergoing a significant transformation, with the changing landscapes of the HCIT industry. The key factors propelling the growth of the global ambulatory EHR market are government support for the adoption of HCIT, growing usage of EHR solutions, and the need to curtail healthcare costs. On the other hand, heavy infrastructure investments and the high cost of deployment are limiting the growth of the global ambulatory EHR market to a certain extent. In 2016, North America accounted for the largest share of the global ambulatory EHR market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).Factors such as collaborations between stakeholders, the need to curtail escalating healthcare costs in the U.S., digital health measures, and continuous support in the form of grants in Canada have contributed to the large share of North America in the ambulatory EHR market. Asia-Pacific is projected to have the highest growth rate in the forecast period. Factors such as Japan’s favorable outlook for HCIT, investments and reforms to modernize China’s healthcare infrastructure, digital healthcare scenario in India, and the implementation of e-Health in Australia are likely to boost market growth in the region. The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches; expansions; and agreements, collaborations, and partnerships) to increase their market shares and establish a strong foothold in the global market. Ask For Discount on Ambulatory EHR Market Research Report At: https://goo.gl/wJKDfU In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the ambulatory EHR marketplace. • By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8% • By Designation: Director Level: 58%, C-level: 25%, Others: 17% • By Region: North America: 51.9%, Europe: 32.6%, APAC: 10.5%, RoW: 5.0% The major market players in the ambulatory EHR market include Cerner Corporation (U.S.), McKesson Corporation (U.S.), All scripts Healthcare Solutions, Inc. (U.S.), Epic Systems Corporation (U.S.), eClinical Works (U.S.), Athena health, Inc. (U.S.), Next Gen Healthcare Information Systems, LLC (U.S.), eMDs, Inc. (U.S.), Practice Fusion, Inc. (U.S.), Amazing Charts, LLC (U.S.), GE Healthcare (U.S.), and Greenway Health, LLC (U.S.). The report provides an overall understanding of the market. In this report, the market is segmented on the basis of application, delivery mode, practice size, end user, and region. Based on application, the market is divided into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics. Based on delivery mode, the market is segmented into cloud-based solutions and on-premises solutions. Based on practice size, the market is categorized into large practices, small-to-medium practices, and solo practices. The end-user segment includes hospital-owned ambulatory centers and independent centers. The regional segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers: • Market Penetration: Comprehensive information on the products and services offered by top players in the ambulatory EHR market. • Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product launches in the ambulatory EHR market • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for ambulatory EHR devices across regions • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the ambulatory EHR market • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the ambulatory EHR market Order a copy of Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (Practice Management, Patient Management, Referral Management, Health Analytics), Practice Size (Large, Small-to-medium, Solo), End User - Global Forecast to 2021 Research report at: https://goo.gl/Tvs0zS ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more. For more information, please visit http://www.rnrmarketresearch.com/ambulatory-ehr-market-by-delivery-mode-cloud-based-on-premise-application-practice-management-patient-management-referral-management-health-analytics-practice-size-large-small-to-medium-solo-end-user-st-to-2021-market-report.html


Browse 20 Exhibits, 4 Major Company Profiles, spread across 70 pages available at http://www.reportsnreports.com/reports/985436-global-pharmacy-management-system-market-2017-2021.html. According to the pharmacy management system market report, one driver in market is rising need to automate process. The pharmacy management system providers also provide pharmacies with an online e-commerce platform, pharma cycle, connecting them to the main drug suppliers in the region or area they operate. The pharmacy management systems have become a vital component of any pharmacy that wants to be competitive in the market, and deliver better care to their customers through an efficient and automated process. The pharmacy management systems aid pharmacies to customize and streamline their workflow with a range of functions and features that improve efficiency, safety, and profitability. The following companies as the key players in the global pharmacy management systems market: Allscripts, Epicor Software, Cerner Corporation, and McKesson Corporation. Other prominent vendors in the market are: ACG Infotech, Clanwilliam Health, Datascan, Foundation Systems, GlobeMed, Health Business Systems, Idhasoft, Liberty Software, LS Retail, MedHOK, Mobile MedSoft, Panama Technologies, PioneerRx, Safe Care Technologies, and ScriptPro. Order a copy of Global Pharmacy Management System Market 2017-2021 research report at http://www.reportsnreports.com/purchase.aspx?name=985436. Global Pharmacy Management Systems Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the present scenario and the growth prospects and to calculate the market size, the report considers the revenue generated from the sales of pharmacy management system across the globe. Global Medical Imaging Software Market 2017-2021 - The medical imaging software enables the use of medical imaging devices for viewing and analyzing medical images. The increased adoption of medical imaging software in the diagnosis of chronic diseases is expected to drive the market growth of the global medical imaging software market during the forecast period. Global Workforce Management Software Market 2017-2021 - The analysts forecast global workforce management software market to grow at a CAGR of 8.49% during the period 2017-2021. Global Beacon Management Software Market 2017-2021 - Beacon management software solutions provide a secure and safe path for transferring and integrating data from beacons to other software such as CRM software and social analytics tools. Many companies, such as Simon Property Group, have installed more than 4,000 beacons in over 190 malls and shopping centers worldwide. Explore more reports on Healthcare at http://www.reportsnreports.com/market-research/healthcare/. ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Browse 20 Exhibits, 4 Major Company Profiles, spread across 70 pages available at http://www.reportsnreports.com/reports/985436-global-pharmacy-management-system-market-2017-2021.html. According to the pharmacy management system market report, one driver in market is rising need to automate process. The pharmacy management system providers also provide pharmacies with an online e-commerce platform, pharma cycle, connecting them to the main drug suppliers in the region or area they operate. The pharmacy management systems have become a vital component of any pharmacy that wants to be competitive in the market, and deliver better care to their customers through an efficient and automated process. The pharmacy management systems aid pharmacies to customize and streamline their workflow with a range of functions and features that improve efficiency, safety, and profitability. The following companies as the key players in the global pharmacy management systems market: Allscripts, Epicor Software, Cerner Corporation, and McKesson Corporation. Other prominent vendors in the market are: ACG Infotech, Clanwilliam Health, Datascan, Foundation Systems, GlobeMed, Health Business Systems, Idhasoft, Liberty Software, LS Retail, MedHOK, Mobile MedSoft, Panama Technologies, PioneerRx, Safe Care Technologies, and ScriptPro. Order a copy of Global Pharmacy Management System Market 2017-2021 research report at http://www.reportsnreports.com/purchase.aspx?name=985436. Global Pharmacy Management Systems Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the present scenario and the growth prospects and to calculate the market size, the report considers the revenue generated from the sales of pharmacy management system across the globe. Global Medical Imaging Software Market 2017-2021 - The medical imaging software enables the use of medical imaging devices for viewing and analyzing medical images. The increased adoption of medical imaging software in the diagnosis of chronic diseases is expected to drive the market growth of the global medical imaging software market during the forecast period. Global Workforce Management Software Market 2017-2021 - The analysts forecast global workforce management software market to grow at a CAGR of 8.49% during the period 2017-2021. Global Beacon Management Software Market 2017-2021 - Beacon management software solutions provide a secure and safe path for transferring and integrating data from beacons to other software such as CRM software and social analytics tools. Many companies, such as Simon Property Group, have installed more than 4,000 beacons in over 190 malls and shopping centers worldwide. Explore more reports on Healthcare at http://www.reportsnreports.com/market-research/healthcare/. ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


News Article | May 10, 2017
Site: www.prnewswire.com

LONDON, May 10, 2017 /PRNewswire/ -- About Pharmacy Management Systems Pharmacy management system helps to improve and automate every major pharmacy process. Developed for ease-of-use, the solution features accessibility in just a click, thereby, increasing the speed of transaction processing and profitability. The pharmacy software enables easy processing of new prescriptions and keeps a track on the stock of drugs available at the pharmacy and the physician. Additionally, it manages purchase orders, tracks the inventory requirement efficiently, maintains the entire supply chain, and the drug order maintenance. It upholds the purchase indents, quotation entry, stock audit, and connectivity with retail store. Download the full report: https://www.reportbuyer.com/product/4886861/ Technavio's analysts forecast the global pharmacy management systems market to grow at a CAGR of 10.93% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global pharmacy management systems market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of pharmacy management system across the globe. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Pharmacy Management Systems Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Allscripts • Epicor Software • Cerner Corporation • McKesson Corporation Other prominent vendors • ACG Infotech • Clanwilliam Health • Datascan • Foundation Systems • GlobeMed • Health Business Systems • Idhasoft • Liberty Software • LS Retail • MedHOK • Mobile MedSoft • Panama Technologies • PioneerRx • Safe Care Technologies • ScriptPro Market driver • Adherence to compliance of pharmaceutical industry. • For a full, detailed list, view our report Market challenge • Selection of vendors according to specific needs. • For a full, detailed list, view our report Market trend • Introduction of new features in the pharmacy management system. • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report. Methodology Download the full report: https://www.reportbuyer.com/product/4886861/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-pharmacy-management-system-market-2017-2021-300455487.html

Loading Cerner Corporation collaborators
Loading Cerner Corporation collaborators